| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.9M | +13.3% |
| Cost of Revenue | $5.3M | +7.4% |
| Gross Profit | $8.6M | +17.2% |
| R&D Expense | $611K | +5.8% |
| SG&A Expense | $4.0M | +13.1% |
| Operating Income | $7K | +100.9% |
| Income Tax | $0 | — |
| Net Income | $9K | +101.0% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | -27.6% |
| Accounts Receivable | $1.5M | +3.5% |
| Inventory | $821K | -11.5% |
| Current Assets | $5.0M | -13.4% |
| Total Assets | $17.2M | +1.5% |
| Current Liabilities | $3.3M | +1.7% |
| Long-term Debt | $2.2M | +7.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $639K | +9.6% |
| Capital Expenditures | $721K | +383.8% |
| Investing Cash Flow | -$685K | -359.7% |
| Financing Cash Flow | -$145K | -80.4% |
| Free Cash Flow | -$82K | -119.0% |
| — |
| EPS (Diluted) | $0.00 | — |
| Total Liabilities |
| $12.8M |
| -0.4% |
| Stockholders' Equity | $4.3M | +7.7% |